Tuesday - June 9, 2026
HKUMed develops novel combination therapy to reduce leukaemia relapse rate, extending window for bone marrow transplants
May 20, 2026
HONG KONG, May 20 -- The University of Hong Kong issued the following news release:

* * *

HKUMed develops novel combination therapy to reduce leukaemia relapse rate, extending window for bone marrow transplants

*

A research team from the Department of Medicine, School of Clinical Medicine, LKS Faculty of Medicine, the University of Hong Kong (HKUMed), has developed a novel combination therapy that significantly improves treatment outcomes and s . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products